Hit enter to search or ESC to close
Talis
  • Technology
  • Company
  • Careers
  • News
  • Contact
Uncategorized
July 31, 2020

Talis Awarded NIH RADx Contract to Launch Talis One™ System for Point-of-Care COVID-19 Testing and Further Strengthens Financial Position and Leadership Team

Company awarded $25 million in NIH RADx contract and secures $100 million new financing  Industry…
Kris
Love0
PR
October 11, 2018

Talis Biomedical Corporation announces expansion of Scientific Advisory Board

Jane Schwebke, M.D., joins the Talis SAB MENLO PARK, Calif., Oct. 11, 2018 /PRNewswire/ --…
Talis
Love1
PR
August 29, 2018

Talis Biomedical Corporation awarded $5.6M by NIH

Talis Bio is developing a high-performance molecular point-of-care (POC) diagnostic platform to enable physician offices and…
Talis
Love2
PR
August 29, 2018

Talis Bio awarded $4.4M by CARB-X

Talis is developing a high-performance diagnostic platform to enable physician offices and clinics to run reference…
Talis
Love0


Talis is dedicated to providing broad access to fast, highly accurate, actionable diagnostic testing at the point of care to ensure better treatment and disease management for patients with COVID-19 and other infectious diseases.

  • Home
  • Technology
  • Company
  • News
  • Careers
  • Contact
Talis Biomedical

Menlo Park
230 Constitution Dr.
Menlo Park, CA 94025

Chicago
125 S Clark Street, 17th Floor
Chicago, IL 60603

info@talisbio.com
650-433-3000

©2020 Talis Biomedical. All Rights Reserved.

  • Technology
  • Company
  • Careers
  • News
  • Contact